Seven Eight Capital, LP Enovis Corp Transaction History

Seven Eight Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$44.56 - $62.43 $579,636 - $812,089	13,008 New	13,008 $587,000
Q3 2023 Nov 14, 2023	BUY	$51.65 - $65.54 $213,521 - $270,942	4,134 New	4,134 $217,000
Q1 2023 May 12, 2023	BUY	$49.5 - $65.92 $364,518 - $485,434	7,364 New	7,364 $393,000
Q3 2022 Nov 10, 2022	BUY	$46.07 - $60.1 $209,710 - $273,575	4,552 New	4,552 $210,000

310

60.2M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.38B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.